How to Buy Alterity Therapeutics Stock
Alterity Therapeutics Ltd
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia.
Alterity Therapeutics stock last closed at $3.46, down 0.29% from the previous day, and has increased 65.16% in one year. It has overperformed other stocks in the Biotechnology industry by 1.42 percentage points. Alterity Therapeutics stock is currently +245.65% from its 52-week low of $1.00, and -41.06% from its 52-week high of $5.87.
At the moment, there are 5.32B ATHE shares outstanding. The market cap of ATHE is $36.82M. In the last 24 hours, 5551 ATHE shares were traded.
How to Buy Alterity Therapeutics Stock
Wondering how to invest in Alterity Therapeutics stock? Here's how.
- Figure out where to buy Alterity Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Alterity Therapeutics stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Choose your payment method and add your details.
- Evaluate Alterity Therapeutics stock: The Alterity Therapeutics ticker symbol is ATHE. Is Alterity Therapeutics stock a good investment? Should you buy shares of ATHE? How do ATHE's underlying business fundamentals look? Do top analysts think Alterity Therapeutics is a good buy? Why has ATHE's stock price moved recently? (Hint: Our stock research website can help you figure out if ATHE is a good stock to buy).
- Place your ATHE purchase: Decide if you will purchase ATHE shares at the current market price or use a limit order to buy ATHE stock at a specific price.
- Get the latest scoop on your ATHE investment: Create a watchlist to get live updates on your position in Alterity Therapeutics shares.
Step 1: Figure out where to buy Alterity Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy ATHE stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you can invest in ATHE today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create your new brokerage account.
- Send your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've filled out your info on a good stock buying app, your next step is to transfer the money for your investment:
Check out this video walkthrough if you need help transferring funds into your new investment account.
Step 4: Evaluate Alterity Therapeutics stock
Once you have chosen the best place to buy Alterity Therapeutics stock, it's crucial to evaluate their stock prior to buying, so you truly understand the risk as well as the opportunity.
Overview of key ATHE info
Alterity Therapeutics Due Diligence Score
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ATHE's stock page.
Is ATHE stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge ATHE's intrinsic value.
Using relative valuations measures:
- ATHE may be overvalued based on its P/B ratio of 7.52x, relative to Biotechnology industry P/B ratio of 4.45x
You can access more valuation analysis on ATHE's stock here.
ATHE Financial Health Summary
Signs that ATHE is financially healthy:
- ATHE has a low debt to equity ratio of 0.36.
- There are more short-term assets than long-term liabilities on the ATHE balance sheet.
- There are more short-term assets than short-term liabilities on the ATHE balance sheet.
Signs that ATHE is not financially healthy:
- ATHE has cash burn of 10358808. It does not have enough cash and short-term investments to cover this.
- Total ATHE debt is higher than 5 years ago, relative to shareholder equity.
- ATHE has $2.85M in cash and short term investments. This is not enough to cover its annual cash burn of $10.36M.
- ATHE profit margin has gone down from -357.9% to -531.3% in the past year.
Do Wall Street analysts think it's a good time to buy Alterity Therapeutics stock
Out of 1 Wall Street analysts who give recommendations on ATHE, the consensus analyst rating on ATHE is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Alterity Therapeutics stock forecast page.
ATHE Technical Indicators
Is ATHE Making Money?
Last year, ATHE revenue was $2.34M. Over the past five year, ATHE's revenue has grown by -5.46% per year. This was slower than the Biotechnology industry average of 45.66%.
Learn more about ATHE's earnings and revenue performance here.
Latest Insiders Trades at ATHE
Over the past year, executives and large shareholders at ATHE have not bought or sold any shares.
Get more info about who owns ATHE stock here.
Can I get consistent income from ATHE stock?
No, Alterity Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about ATHE?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your ATHE purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open Trade button and eToro will execute the order.
If you need additional help investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest scoop on your ATHE investment
Now that you own some ATHE shares, you'll want to keep up with your company.
Start a watchlist to get the latest updates about your ATHE stock.
ATHE Feed
How to Buy Stock in Alterity Therapeutics
To reiterate, here are the 6 steps for buying Alterity Therapeutics stock:
- Figure out where to buy Alterity Therapeutics stock
- Create your brokerage account
- Put funds into your brokerage account
- Evaluate Alterity Therapeutics stock
- Place your ATHE purchase
- Get the latest scoop on your ATHE investment
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Alterity Therapeutics, get started below.
More "How To" Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.